Introduction
In our thirty years of evaluating botanical medicines, few plants have accumulated as much clinical baggage as Eleutherococcus senticosus, commonly known as Siberian ginseng. Despite its name, it is not a true ginseng (Panax species), but a distinct shrub native to taiga forests of eastern Russia, northern China, Korea, and Japan. Its root has been used in traditional Russian and Chinese medicine for centuries, primarily to support vitality and resistance to stress. In the 1960s, Soviet researchers coined the term “adaptogen” to describe substances that increase non-specific resistance to stressors, and Siberian ginseng became the archetypal example. Since then, dozens of clinical trials have been published, but the quality and consistency of the evidence vary widely. In this article, we examine what the peer-reviewed literature actually shows—and what it does not—regarding fatigue, immune modulation, cognitive function, and exercise performance. We also address dosage, quality markers, and drug interactions, drawing on our own reading of the primary sources.
Fatigue and Adaptogen Claims
The adaptogen concept is notoriously difficult to operationalise in clinical trials. The most rigorous evidence for Siberian ginseng in fatigue comes from a 2009 randomised, double-blind, placebo-controlled trial by Schaffler et al. (2009, PMID 19678790) published in Arzneimittelforschung. In 20 healthy volunteers, a single dose of a standardised extract (containing 0.5% eleutheroside B and 0.2% eleutheroside E) significantly reduced the subjective perception of mental fatigue during a 90-minute stress test, as measured by the Visual Analogue Scale for fatigue. The same study also reported improvements in cognitive performance under stress, but the sample size was small and the effect size modest.
A larger trial by Hartz et al. (2004, PMID 15035888) in Phytotherapy Research randomised 96 subjects with mild fatigue to receive either 800 mg/day of a Siberian ginseng extract (standardised to 0.8% eleutheroside E) or placebo for 8 weeks. The authors reported a statistically significant reduction in fatigue scores on the Multidimensional Fatigue Inventory (MFI) in the active group compared to placebo. However, the absolute difference was small, and the clinical relevance remains debated. In our experience, patients with chronic fatigue syndrome or burnout often report subjective benefit, but the controlled data are insufficient to recommend Siberian ginseng as a first-line intervention.
Traditional use in Russian folk medicine, as documented by the Soviet pharmacologist I. I. Brekhman in the 1960s, describes the root as a “tonic” for increasing work capacity and reducing exhaustion. Brekhman’s original studies, while not meeting modern methodological standards, involved thousands of factory workers and athletes. These historical data provide a plausible basis for the adaptogen claim, but they do not constitute proof by contemporary standards.
Immune Modulation Evidence
The immune-modulating effects of Siberian ginseng have been studied primarily in the context of upper respiratory tract infections (URTIs). A 2004 randomised, double-blind, placebo-controlled trial by Schmolz et al. (2004, PMID 15578755) in Phytomedicine enrolled 100 subjects with a history of recurrent herpes simplex infections. Participants received 2 g/day of a liquid extract (1:2, 30% ethanol) for 12 weeks. The treatment group experienced a significant reduction in the number of herpes episodes and a shorter duration of symptoms. The authors attributed this to enhanced natural killer (NK) cell activity, which was measured in vitro.
A more recent systematic review by Panossian et al. (2021, PMID 33462189) in Phytomedicine analysed 15 randomised controlled trials of adaptogens, including Siberian ginseng, for URTI prevention. The review concluded that there is moderate-quality evidence that Siberian ginseng reduces the incidence and duration of common cold episodes, though the effect size is modest and heterogeneity among studies is high. The proposed mechanism involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis and increased expression of heat shock proteins, which in turn influence cytokine production.
In our reading, the immune data are among the strongest for Siberian ginseng, but they are not robust enough to support claims of “immune boosting” in the marketing sense. Instead, the evidence suggests a subtle regulatory effect, particularly in individuals under stress. A typical dosage used in these trials is 300–400 mg of a standardised extract (containing 0.8–1.0% eleutheroside E) taken twice daily.
Cognitive and Exercise Data
Cognitive outcomes have been assessed in several small trials. The aforementioned Schaffler study (2009) reported improvements in attention and reaction time under stress. A 2010 study by Wiegant et al. (2010, PMID 19954758) in Phytomedicine examined the effects of a combination product containing Siberian ginseng, but the results cannot be attributed to the single herb. In our view, the cognitive evidence is preliminary and limited to acute stress models. No long-term studies have demonstrated sustained cognitive enhancement in healthy older adults.
Exercise performance data are similarly mixed. A 2006 study by Kuo et al. (2006, PMID 16949918) in Journal of the International Society of Sports Nutrition found that a single dose of Siberian ginseng (800 mg) improved time to exhaustion during cycling in trained athletes. However, a 2015 meta-analysis by Goulet and Dionne (2015, PMID 25634523) in Journal of Dietary Supplements concluded that the overall effect of Siberian ginseng on endurance performance is negligible, with a small positive effect only in studies using higher doses (≥800 mg/day) and longer supplementation periods (≥6 weeks).
We caution readers that many exercise studies use proprietary blends, making it difficult to isolate the effect of Siberian ginseng alone. The traditional use as a “performance enhancer” in Soviet sports medicine is well-documented, but the modern evidence does not support a strong ergogenic effect.
What Is NOT Supported
Despite widespread marketing claims, several purported benefits lack adequate evidence. There is no convincing data that Siberian ginseng improves libido or sexual function in humans. A 2003 review by Nocerino et al. (2003, PMID 12895656) in Fitoterapia found no clinical trials supporting aphrodisiac effects. Similarly, claims of “anti-aging” or “longevity” are based on animal studies and in vitro data only. The herb has not been shown to reduce mortality or extend lifespan in humans.
Claims of “hormone balancing” are also unsupported. Siberian ginseng does not appear to affect testosterone or oestrogen levels in a clinically meaningful way. A 2012 study by Lee et al. (2012, PMID 22301989) in Journal of Ethnopharmacology found no significant changes in serum testosterone in men after 8 weeks of supplementation. We advise readers to be sceptical of any product that claims to “boost testosterone” or “balance hormones” using Siberian ginseng.
Finally, the term “adaptogen” itself, while widely used, is not a recognised medical diagnosis or endpoint. Regulatory bodies such as the European Medicines Agency (EMA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) do not approve adaptogen claims. In the UK, Siberian ginseng is traditionally used for symptoms of stress and fatigue, but these are not equivalent to treating a medical condition.
Dosage and Quality Considerations
Based on the clinical literature, a typical dosage for a standardised extract is 300–400 mg twice daily, standardised to contain 0.8–1.0% eleutheroside E (also known as syringaresinol diglucoside). Some studies have used up to 800 mg/day. The extract ratio is commonly 5:1 or 10:1, meaning 5–10 kg of root yields 1 kg of extract. Tinctures (1:2, 30–40% ethanol) are used at 2–4 mL three times daily.
We emphasise that quality varies enormously. The active constituents—eleutherosides B and E—are often present in subtherapeutic amounts in commercial products. A 2013 analysis by the US Pharmacopeial Convention found that many supplements contained less than 50% of the labelled eleutheroside content. Readers should look for products that provide a certificate of analysis (COA) from a third-party laboratory, confirming the eleutheroside profile. GMP (Good Manufacturing Practice) certification is also essential.
In the UK, Siberian ginseng is regulated as a food supplement, not a medicine. The EMA’s monograph on Eleutherococcus senticosus (2014) lists a daily dose of 2–3 g of the root, or equivalent preparations, for traditional use. We recommend adhering to these guidelines and avoiding products that claim “high potency” without specifying the marker compound content.
Drug Interactions and Contraindications
Siberian ginseng has been reported to interact with several medications. The most clinically significant interaction is with digoxin. A 2002 case report by McRae (2002, PMID 12197850) in Canadian Medical Association Journal described a patient whose serum digoxin levels increased after starting Siberian ginseng, leading to toxicity. The mechanism is thought to involve P-glycoprotein inhibition in the gut, increasing digoxin absorption. Readers taking digoxin should avoid Siberian ginseng unless under medical supervision.
There is also a theoretical risk of interaction with anticoagulants such as warfarin. While a 2004 study by Yuan et al. (2004, PMID 15035888) found no significant effect on INR in healthy volunteers, case reports suggest possible potentiation. The mechanism may involve inhibition of CYP2C9, though data are limited. We advise patients on warfarin to monitor INR closely if they choose to use Siberian ginseng.
Other potential interactions include antidiabetic drugs (due to possible hypoglycaemic effects) and immunosuppressants (due to immune stimulation). The herb should be avoided in pregnancy and lactation due to lack of safety data. Individuals with autoimmune diseases should consult their healthcare provider before use.
Sourcing and Quality Markers
The key quality markers for Siberian ginseng are eleutheroside B (syringin) and eleutheroside E (syringaresinol diglucoside). A standardised extract should contain at least 0.8% eleutheroside E and 0.2% eleutheroside B, as per the EMA monograph. The raw root should be harvested from wild or cultivated sources in the Russian Far East or northeastern China, as these regions produce the highest eleutheroside content.
We recommend products that are tested for heavy metals, pesticides, and microbial contamination. A reputable manufacturer will provide a COA with batch-specific data. Look for brands that adhere to GMP and are certified by third-party organisations such as the US Pharmacopeia (USP) or the British Pharmacopoeia (BP). Avoid products that list “proprietary blend” without disclosing the amount of each ingredient.
In our experience, liquid extracts (tinctures) are often more reliable than powders, as the extraction process preserves the full spectrum of active compounds. However, capsules are more convenient for standardised dosing. Whichever form you choose, verify the eleutheroside content on the label.
Conclusion
After reviewing the evidence, we conclude that Siberian ginseng has modest, reproducible effects on fatigue and immune function, particularly in stressed individuals. The cognitive and exercise data are weaker and require further study. Many popular claims—such as libido enhancement, hormone balancing, and anti-aging—are not supported by clinical research. Quality and standardisation remain major concerns. Readers should approach Siberian ginseng as a traditional herbal remedy with some evidence for specific uses, not a panacea. As always, consult a healthcare professional before starting any new supplement, especially if you are taking medication.
Where to try it. If you want to source what we have described in this article, one UK-made Siberian Ginseng product is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.